StackTerminal.Health

BETA
Research compound

This compound is primarily studied in research/clinical settings & may not be widely available as a regulated over-the-counter supplement. Information is provided for educational purposes only — not as a recommendation to use. See our Safety page.

MDMA

MDMA is an entactogenic compound used in clinical trials for MDMA-assisted psychotherapy, showing significant remission rates for PTSD treatment.

mental-healthptsdanxietypsychotherapy
Evidence last reviewed: 05 Apr 2026
Supplement note
Private note on this supplement

Save how you reacted, what dose worked, what to watch for, or anything you want to remember later in your Notes tab.

Sign in to keep a private note on MDMA.
Evidence
4 records
PTSD symptom reduction
Patients with severe PTSDRCT
PUBMEDHigh

MDMA-assisted therapy significantly reduced PTSD symptoms compared to placebo.

Dose: 120 mgDuration: 12 weeksForm: CapsuleTiming: During therapy sessions
PTSD symptom reduction
Patients with moderate to severe PTSDRCT
PUBMEDHigh

MDMA-AT led to significant reductions in PTSD severity scores & increased remission rates.

Dose: 120 mgDuration: 12 weeksForm: CapsuleTiming: During therapy sessions
PTSD symptom reduction
Military veterans, firefighters, and police officers with PTSDRCT
PUBMEDModerate

Dose-response study showed significant PTSD symptom reduction with MDMA-AT.

Dose: 75 mgDuration: 12 weeksForm: CapsuleTiming: During therapy sessions
PTSD symptom reduction
Patients with chronic, treatment-resistant PTSDMeta-analysis
PUBMEDHigh

Meta-analysis supports significant efficacy of MDMA-AT in improving PTSD symptoms.

Dose: 120 mg
Forms
Capsule
Typically used in clinical settings for controlled dosing.
Tablet
Less common, but available for research purposes.

Stacks containing MDMA

Public community stacks that include this ingredient.

Explore all stacks →
No public stacks include this ingredient yet.